PMID 1918431
The subcutaneous injections available in the United States are dulaglutide (Trulicity, Eli Lilly, for type 2 diabetes), liraglutide (Victoza, Novo Nordisk, for type 2 diabetes), semaglutide (Ozempic, Novo Nordisk, for type 2 diabetes and Wegovy, for weight loss), tirzepatide (Mounjaro, Eli Lilly, for type 2 diabetes), and Zepbound (Eli Lilly, for weight loss)
Then remove the needle cap
SCFAs stimulate the L-cells and release GLP-1[8]
Legitimate Use Cases Berberine may be useful for: Metabolic syndrome support (alongside lifestyle changes) Prediabetes management Modest cardiovascular risk factor modification Part of a comprehensive approach to metabolic health Effective dosing typically requires 500mg taken 2-3 times daily with mealstotal daily doses of 1,000-1,500mg
Archived from the original on 20 August 2012